Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.
The fungal genus Candida encompasses numerous species that inhabit a variety of hosts, either as commensal microbes and/or pathogens. Candida species are a major cause of fungal infections, yet to date there are no vaccines against Candida or indeed any other fungal pathogen. Our knowledge of immunity to Candida mainly comes from studies on Candida albicans, the most frequent species associated with disease. However, non-albicans Candida (NAC) species also cause disease and their prevalence is increasing. Although research into immunity to NAC species is still at an early stage, it is becoming apparent that immunity to C. albicans differs in important ways from non-albicans species, with important implications for treatment, therapy and predicted demographic susceptibility. This review will discuss the current understanding of immunity to NAC species in the context of immunity to C. albicans, and highlight as-yet unanswered questions.
Division of Rheumatology & Clinical Immunology, Dept. of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Natasha
N
Whibley
Division of Rheumatology & Clinical Immunology, Dept. of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA; Division of Rheumatology & Clinical Immunology, BST S702, 200 Lothrop St., Pittsburgh, PA 15261, USA. Electronic address: sarah.gaffen@pitt.edu.
Sarah L
SL
Gaffen
D000818:Animals; D002175:Candida / Q000276:immunology*; D002176:Candida albicans / Q000276:immunology; D002177:Candidiasis / Q000276:immunology*; D006801:Humans
Candida albicans; Fungal immunity; Non-albicans species